<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-128</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКОЕ И КЛИНИЧЕСКОЕ ИЗУЧЕНИЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL AND CLINICAL STUDY OF MEDICINES</subject></subj-group></article-categories><title-group><article-title>Методические подходы к оценке нейротоксичности фармакологических веществ</article-title><trans-title-group xml:lang="en"><trans-title>Methodological approaches to the assessment of pharmaceutical substances neurotoxicity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>M. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаров</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>V. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шекунова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shekunova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Закрытое акционерное общество «Научно-производственное объединение «ДОМ ФАРМАЦИИ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>CJSC Scientific-Production Association «HOME OF PHARMACY»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2018</year></pub-date><volume>7</volume><issue>2</issue><fpage>111</fpage><lpage>116</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Макарова М.Н., Макаров В.Г., Шекунова Е.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Макарова М.Н., Макаров В.Г., Шекунова Е.В.</copyright-holder><copyright-holder xml:lang="en">Makarova M.N., Makarov V.G., Shekunova E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/128">https://www.vedomostincesmp.ru/jour/article/view/128</self-uri><abstract><p>В статье рассмотрены методические подходы к оценке нейротоксичности фармакологических веществ. Описана основная батарея тестов на животных, проводимая до начала клинических исследований для оценки влияния препарата на функцию жизненно-важных систем организма. Рассмотрены такие аспекты, как выбор вида животных, выбор дозы и длительность введения фармакологического вещества, проведение клинического обследования, функциональных тестов и гистологических исследований. Отмечено, что правильное обоснование программы исследования может позволить существенно сократить перечень исследований. Обоснована целесообразность использования не менее двух видов животных для оценки нейротоксичности, с обязательным использованием не грызунов, результаты которой позволят в максимально возможном объеме в ходе доклинических исследований изучить профиль безопасности лекарственного препарата и обеспечат необходимый уровень безопасности для человека при переходе на I фазу клинических исследований.</p></abstract><trans-abstract xml:lang="en"><p>The article reviews methodological approaches to the assessment of pharmaceutical substances neurotoxicity. It describes the main battery of animal tests that are conducted prior to clinical trials in order to assess drug effects on the functioning of vital body systems. The article addresses the choice of animal species, dosage and duration of pharmaceutical substance administration, as well as the conduct of clinical trials, functional tests and histological studies. It points out that an adequate justification of the study programme may help substantially reduce the number of tests. The authors assert the need to use at least two animal species in neurotoxicity studies, one of which must be a non-rodent species, in order to be able to investigate the drug safety profile during preclinical studies in as much detail as possible and to assure the required safety level for people when moving on to Phase I of clinical trials.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нейротоксичность</kwd><kwd>нервная система</kwd><kwd>координация движений</kwd><kwd>сенсорные реакции</kwd><kwd>когнитивные функции</kwd><kwd>фармакологическая безопасность</kwd><kwd>лабораторные животные</kwd><kwd>neurotoxicity</kwd><kwd>nervous system</kwd><kwd>motor coordination</kwd><kwd>sensory reactions</kwd><kwd>cognitive functions</kwd><kwd>safety pharmacology</kwd><kwd>laboratory animals</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Safety Pharmacology Studies for Human Pharmaceuticals (ICH Topic S7A), 2000. Available from: https://goo.gl/H0MQFy.</mixed-citation><mixed-citation xml:lang="en">Safety Pharmacology Studies for Human Pharmaceuticals (ICH Topic S7A), 2000. Available from: https://goo.gl/H0MQFy.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по экспертизе лекарственных средств. Т. I. М.: Гриф и К; 2013.</mixed-citation><mixed-citation xml:lang="en">Guidance on evaluation of medicines. Vol. I. Moscow: Grif i K; 2013 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">ГОСТ Р 56700-2015. Лекарственные средства для медицинского применения. Доклинические фармакологические исследования безопасности. М.: Стандартинформ; 2016.</mixed-citation><mixed-citation xml:lang="en">State Standard R 56700–2015. Medicinal products for human use. Preclinical safety  pharmacology studies. Moscow: Standartinform; 2016 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Енгалычева ГН, Сюбаев РД, Васильев АН, Снегирева АА, Верстакова ОЛ. Оценка фармакологической безопасности лекарственных средств в доклинических исследованиях. Ведомости Научного центра экспертизы средств медицинского применения 2013; (1): 10-3.</mixed-citation><mixed-citation xml:lang="en">Engalycheva GN, Syubaev RD, Vasiliev AN, Snegireva AA, Verstakova OL. Drug  pharmacological safety evaluation in preclinical studies. The Bulletin of the  Scientific Centre for Expert Evaluation of Medicinal Products 2013; (1): 10–3 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968; 13(3): 222-57.</mixed-citation><mixed-citation xml:lang="en">Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative  procedure for assessing the behavioral and physiologic state of the mouse.  Psychopharmacologia 1968; 13(3): 222–57.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Irwin S. Drug screening and evaluation of new compounds in animals. In: Nodin JH, Siegler PE, eds. Animal and clinical techniques in drug evaluation. Chicago: Year Book Medical Publishers; 1964. P. 36-54.</mixed-citation><mixed-citation xml:lang="en">Irwin S. Drug screening and evaluation of new compounds in animals. In: Nodin JH,  Siegler PE, eds. Animal and clinical techniques in drug evaluation. Chicago: Year  Book Medical Publishers; 1964. P. 36–54.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Зильбер ЮД. Влияние трикрезилфосфата на миелиновые оболочки и его мембранотоксическое действие (Некоторые вопросы патогенеза отравлений): автореф. дис. … д-ра мед. наук. М.; 1971.</mixed-citation><mixed-citation xml:lang="en">Zilber YuD. The effect of tricresyl phosphate on myelin sheaths and its membrane  toxicity (Some aspects of poisoning pathogenesis). Dr. Med. Sci [thesis]. Moscow; 1971 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mullins RJ, Xu S, Pereira EF, Pescrille JD, Todd SW, Mamczarz J, et al. Prenatal exposure of guinea pigs to the organophosphorus pesticide chlorpyrifos disrupts the structural and functional integrity of the brain. Neurotoxicology 2015; 48: 9-20.</mixed-citation><mixed-citation xml:lang="en">Mullins RJ, Xu S, Pereira EF, Pescrille JD, Todd SW, Mamczarz J, et al. Prenatal  exposure of guinea pigs to the organophosphorus pesticide chlorpyrifos disrupts the  structural and functional integrity of the brain. Neurotoxicology 2015; 48: 9–20.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dobbing J, Sands J. Growth and development of the brain and spinal cord of the guinea pig. Brain Res. 1970; 17(1): 115-23.</mixed-citation><mixed-citation xml:lang="en">Dobbing J, Sands J. Growth and development of the brain and spinal cord of the guinea pig. Brain Res. 1970; 17(1): 115–23.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Inns RH, Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol. 1983; 35(7): 427-33.</mixed-citation><mixed-citation xml:lang="en">Inns RH, Leadbeater L. The efficacy of bispyridinium derivatives in the  treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol. 1983; 35(7): 427–33.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fonnum F, Sterri SH, Aas P, Johnsen H. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes. Fundam Appl Toxicol. 1985; 5(6 Pt 2): S29-38.</mixed-citation><mixed-citation xml:lang="en">Fonnum F, Sterri SH, Aas P, Johnsen H. Carboxylesterases, importance for  detoxification of organophosphorus anticholinesterases and trichothecenes. Fundam Appl Toxicol. 1985; 5(6 Pt 2): S29–38.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеева ОИ, Макарова МН, Макаров ВГ. Особенности изучения общетоксических свойств антипсихотических средств. Фармация 2017; (4). В печати.</mixed-citation><mixed-citation xml:lang="en">Avdeeva OI, Makarova MN, Makarov VG. Aspects of studying general toxic  properties of antipsychotic agents. Pharmacy 2017; (4) (in Russian). In press.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Moran-Gates T, Massari C, Graulich A, Liegeois JF, Tarazi FI. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes. Journal of Neuroscience Research 2006; 84(3): 675-82.</mixed-citation><mixed-citation xml:lang="en">Moran-Gates T, Massari C, Graulich A, Liegeois JF, Tarazi FI. Long-term effects  of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor  subtypes. Journal of Neuroscience Research 2006; 84(3): 675–82.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Staay FJ, Pouzet B, Mahieu M, Nordquist RE, Schuurman T. The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics. Psychopharmacology 2009; 206(4): 715-29.</mixed-citation><mixed-citation xml:lang="en">Van der Staay FJ, Pouzet B, Mahieu M, Nordquist RE, Schuurman T. The d- amphetamine-treated Göttingen miniature pig: an animal model for assessing  behavioral effects of antipsychotics. Psychopharmacology 2009; 206(4): 715–29.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo. Synapse 2006; 59(4): 211-19.</mixed-citation><mixed-citation xml:lang="en">Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P.  Quantitative autoradiography of ligands for dopamine receptors and transporters in  brain of Göttingen minipig: comparison with results in vivo. Synapse 2006; 59(4): 211–19.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006; 31(10): 2091-120.</mixed-citation><mixed-citation xml:lang="en">Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with  schizophrenia: implications for metabolic disturbances and treatment with second- generation antipsychotic agents. Neuropsychopharmacology 2006; 31(10): 2091–120.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004; 64(20): 2291-314.</mixed-citation><mixed-citation xml:lang="en">Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms,  clinical features and management. Drugs 2004; 64(20): 2291–314.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">ГОСТ Р 56701-2015. Лекарственные средства для медицинского применения. Руководство по планированию доклинических исследований безопасности с целью последующего проведения клинических исследований и регистрации лекарственных средств. М.: Стандартинформ; 2016.</mixed-citation><mixed-citation xml:lang="en">State Standard R 56701–2015. Medicinal products for human use. Guideline on  planning preclinical safety studies for the purpose of subsequently conducting  clinical trials and carrying out authorisation of medicines. Moscow: Standartinform; 2016 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">OECD Guidelines for the Testing of Chemicals, Section 4. Test № 418: Delayed Neurotoxicity of Organophosphorus Substances Following Acute Exposure.</mixed-citation><mixed-citation xml:lang="en">OECD Guidelines for the Testing of Chemicals, Section 4. Test ¹ 418: Delayed  Neurotoxicity of Organophosphorus Substances Following Acute Exposure.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">OECD Guidelines for the Testing of Chemicals, Section 4. Test № 424: Neurotoxicity Study in Rodents.</mixed-citation><mixed-citation xml:lang="en">OECD Guidelines for the Testing of Chemicals, Section 4. Test ¹ 424: Neurotoxicity Study in Rodents.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tupper DE, Wallace RB. Utility of the Neurologic Examination in Rats. Acta Neurobiol Exp. 1980; 40(6): 999-1003.</mixed-citation><mixed-citation xml:lang="en">Tupper DE, Wallace RB. Utility of the Neurologic Examination in Rats. Acta Neurobiol Exp. 1980; 40(6): 999–1003.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gad SC. A Neuromuscular Screen for Use in Industrial Toxicology. J Toxicol Environ Health 1982; 9(5-6): 691-704.</mixed-citation><mixed-citation xml:lang="en">Gad SC. A Neuromuscular Screen for Use in Industrial Toxicology. J Toxicol Environ Health 1982; 9(5–6): 691–704.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Moser VC, McDaniel KM, Phillips PM. Rat Strain and Stock Comparisons Using a Functional Observational Battery: Baseline Values and Effects of Amitraz. Toxicol Appl Pharmacol. 1991; 108(2): 267-83.</mixed-citation><mixed-citation xml:lang="en">Moser VC, McDaniel KM, Phillips PM. Rat Strain and Stock Comparisons Using a  Functional Observational Battery: Baseline Values and Effects of Amitraz. Toxicol  Appl Pharmacol. 1991; 108(2): 267–83.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Meyer OA, Tilson HA, Byrd WC, Riley MT. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1979; 1(3): 233-6.</mixed-citation><mixed-citation xml:lang="en">Meyer OA, Tilson HA, Byrd WC, Riley MT. A method for the routine assessment of  fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1979; 1(3): 233–6.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Crofton KM, Howard JL, Moser VC, Gill MW, Reiter LW, Tilson HA, MacPhail RC. Interlaboratory Comparison of Motor Activity Experiments: Implication for Neurotoxicological Assessments. Neurotoxicol Teratol. 1991; 13(6): 599-609.</mixed-citation><mixed-citation xml:lang="en">Crofton KM, Howard JL, Moser VC, Gill MW, Reiter LW, Tilson HA, MacPhail RC.  Interlaboratory Comparison of Motor Activity Experiments: Implication for  Neurotoxicological Assessments. Neurotoxicol Teratol. 1991; 13(6): 599–609.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Environmental Health Criteria Document 60: Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals. World Health Organization, 1986.</mixed-citation><mixed-citation xml:lang="en">Environmental Health Criteria Document 60: Principles and Methods for the  Assessment of Neurotoxicity Associated with Exposure to Chemicals. World Health Organization, 1986.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Spencer PS, Schaumburg HH. Experimental and Clinical Neurotoxicology. Baltimore/London: Williams and Wilkins; 1980.</mixed-citation><mixed-citation xml:lang="en">Spencer PS, Schaumburg HH. Experimental and Clinical Neurotoxicology. Baltimore/London: Williams and Wilkins; 1980.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bancroft JD, Steven A. Chapter 17. Theory and Practice of Histological Techniques. In: Neuropathological Techniques. Churchill Livingstone: Lowe, James and Cox; 1990.</mixed-citation><mixed-citation xml:lang="en">Bancroft JD, Steven A. Chapter 17. Theory and Practice of Histological Techniques. In: Neuropathological Techniques. Churchill Livingstone: Lowe, James and Cox; 1990.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Abou-Donia MB, Graham DG. Delayed neurotoxicity of subchronic oral administration of leptophos to hens: recovery during four months after exposure. J Toxicol Environ Health. 1979; 5(6): 1133-47.</mixed-citation><mixed-citation xml:lang="en">Abou-Donia MB, Graham DG. Delayed neurotoxicity of subchronic oral  administration of leptophos to hens: recovery during four months after exposure. J  Toxicol Environ Health. 1979; 5(6): 1133–47.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Konno N, Katoh K, Yamauchi T, Fukushima M. The effects of drug metabolism inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in hens following a single intravenous administration. J Toxicol Sci. 1988; 13(1): 17-30.</mixed-citation><mixed-citation xml:lang="en">Konno N, Katoh K, Yamauchi T, Fukushima M. The effects of drug metabolism  inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in  hens following a single intravenous administration. J Toxicol Sci. 1988; 13(1): 17–30.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Yamauchi T, Katoh K, Konno N, Fukushima M. Delayed neurotoxicity and toxicokinetics of leptophos in hens given repeatedly by low-dose intravenous injections. J Toxicol Sci. 1989; 14(1): 11-21.</mixed-citation><mixed-citation xml:lang="en">Yamauchi T, Katoh K, Konno N, Fukushima M. Delayed neurotoxicity and  toxicokinetics of leptophos in hens given repeatedly by low-dose intravenous injections. J Toxicol Sci. 1989; 14(1): 11–21.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kapoor A, Matthews SG. Prenatal stress modifies behavior and hypothalamic-pituitary-adrenal function in female guinea pig offspring: effects of timing of prenatal stress and stage of reproductive cycle. Endocrinology 2008; 149(12): 6406-15.</mixed-citation><mixed-citation xml:lang="en">Kapoor A, Matthews SG. Prenatal stress modifies behavior and hypothalamic-pituitary-adrenal function in female guinea pig offspring: effects of timing of  prenatal stress and stage of reproductive cycle. Endocrinology 2008; 149(12): 6406–15.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dringenberg HC, Richardson DP, Brien JF, Reynolds JN. Spatial learning in the guinea pig: cued versus non-cued learning, sex differences, and comparison with rats. Behav Brain Res. 2001; 124(1): 97-101.</mixed-citation><mixed-citation xml:lang="en">Dringenberg HC, Richardson DP, Brien JF, Reynolds JN. Spatial learning in the  guinea pig: cued versus non-cued learning, sex differences, and comparison with  rats. Behav Brain Res. 2001; 124(1): 97–101.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lewejohann L, Pickel T, Sachser N, Kaiser S. Wild genius - domestic fool? Spatial learning abilities of wild and domestic guinea pigs. Front Zool. 2010; (7): 9.</mixed-citation><mixed-citation xml:lang="en">Lewejohann L, Pickel T, Sachser N, Kaiser S. Wild genius — domestic fool?  Spatial learning abilities of wild and domestic guinea pigs. Front Zool. 2010; (7): 9.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Mattsson JL, Spencer PJ, Albee RR. A performance standard for clinical and functional observation battery examination of rats. J Am Coll Toxicol. 1996; 15(3): 239-54.</mixed-citation><mixed-citation xml:lang="en">Mattsson JL, Spencer PJ, Albee RR. A performance standard for clinical and  functional observation battery examination of rats. J Am Coll Toxicol. 1996; 15(3): 239–54.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Current protocols in toxicology. Vol. 2. New York: Wiley and Sons; 2005.</mixed-citation><mixed-citation xml:lang="en">Current protocols in toxicology. Vol. 2. New York: Wiley and Sons; 2005.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Netto CA, Izquierdo I. On how passive is inhibitory avoidance. Behav Neural Biol. 1985; 43(3): 327-30.</mixed-citation><mixed-citation xml:lang="en">Netto CA, Izquierdo I. On howpassive is inhibitory avoidance. Behav Neural Biol. 1985; 43(3): 327–30.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Boissier JR, Simon P, Aron C. A new method for rapid screening of minor tranquilizers in mice. Europ J Pharmacol. 1968; 4(2): 45-51.</mixed-citation><mixed-citation xml:lang="en">Boissier JR, Simon P, Aron C. A new method for rapid screening of minor tranquilizers in mice. Europ J Pharmacol. 1968; 4(2): 45–51.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Jarvik ME, Kopp R. An improved one-trial learning situation in mice. Psychol Rep. 1967; 21(1): 221-4.</mixed-citation><mixed-citation xml:lang="en">Jarvik ME, Kopp R. An improved one-trial learning situation in mice. Psychol Rep. 1967; 21(1): 221–4.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">King RA, Glasser RL. Duration of electroconvulsive shock-induced retrograde amnesia in rats. Physiol Behav. 1970; 5(3): 335-9.</mixed-citation><mixed-citation xml:lang="en">King RA, Glasser RL. Duration of electroconvulsive shock-induced retrograde amnesia in rats. Physiol Behav. 1970; 5(3): 335–9.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci. 1984; 11(1): 47-60.</mixed-citation><mixed-citation xml:lang="en">Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci. 1984; 11(1): 47–60.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Morris R, Anderson E, Lynch G, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist. Nature 1986; 319(6056): 774-6.</mixed-citation><mixed-citation xml:lang="en">Morris R, Anderson E, Lynch G, Baudry M. Selective impairment of learning and  blockade of long-term potentiation by an N-methyl- D-aspartate receptor antagonist.  Nature 1986; 319(6056): 774–6.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ланкин ВС, Никитин СВ, Трапезов ОВ. Факторы изменчивости мотивированной страхом реакции удаления от человека у мини-свиней селекции ИЦиГ СО РАН. Вавиловский журнал генетики и селекции 2015; 19(5): 613-23.</mixed-citation><mixed-citation xml:lang="en">Lankin VS, Nikitin SV, Trapezov OV. Factors contributing to the variation of the  fearful withdrawal response to humans in minipigs bred at ICG SB RAS. Vavilov  Journal of Genetics and Breeding 2015; 19(5): 613–23 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Lind NM, Arnfred SM, Hemmingsen RP, Hansen AK, Jensen KH. Open field behaviour and reaction to novelty in Göttingen miniature pigs: effects of d-amphetamine and Haloperidol. Scan J Lab Animal Sci. 2005; 32: 103-12.</mixed-citation><mixed-citation xml:lang="en">Lind NM, Arnfred SM, Hemmingsen RP, Hansen AK, Jensen KH. Open field behaviour  and reaction to novelty in Göttingen miniature pigs: effects of d-amphetamine and  Haloperidol. Scan J Lab Animal Sci. 2005; 32: 103–12.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Moustgaard A, Lind NM, Hemmingsen R, Hansen AK. Spontaneous Object Recognition in the Göttingen Minipig. Neural Plast. 2002; 9(4): 255-9.</mixed-citation><mixed-citation xml:lang="en">Moustgaard A, Lind NM, Hemmingsen R, Hansen AK. Spontaneous Object Recognition  in the Göttingen Minipig. Neural Plast. 2002; 9(4): 255–9.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Haagensen AM, Klein AB, Ettrup A, Matthews LR, Sorensen DB. Cognitive Performance of Göttingen Minipigs Is Affected by Diet in a Spatial Hole-Board Discrimination Test. PLoS One 2013; 8(11): e79429.</mixed-citation><mixed-citation xml:lang="en">Haagensen AM, Klein AB, Ettrup A, Matthews LR, Sorensen DB. Cognitive  Performance of Göttingen Minipigs Is Affected by Diet in a Spatial Hole-Board Discrimination Test. PLoS One 2013; 8(11): e79429.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
